The Pharmaceutical Market: Germany

Date: January 31, 2013
Pages: 112
Price:
US$ 1,295.00
License [?]:
Publisher: Espicom Business Intelligence
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: P081F67CFB9EN
Leaflet:

Download PDF Leaflet

The Pharmaceutical Market: Germany
OVERVIEW OF THE PHARMACEUTICAL MARKET IN GERMANY

While the Arzneimittelmarkt-Neuordnungsgesetz ( AMNOG ) legislation will compress drug companies' revenue-earning opportunities in Germany, we believe the government's decision to make the final reimbursement prices of medicines sold in the country publicly available, and the use of reference pricing across the region, will also lead to price reductions in other countries, providing an aggregation of pricing pressures on companies operating throughout Europe . For its part, the German pharmaceutical market is expected to decline in value by a compound annual growth rate (CAGR) of 0.5% through to 2016, as expressed in local currency terms, or by 3.4% in US dollars.

Headline Expenditure Projections

Pharmaceuticals: EUR39.67bn (US$55.15bn) in 2011 to EUR38.65bn (US$49.08bn) in 2012; -2.6% in local currency terms and -11.0% in US dollar terms. Forecast unchanged from Q4 12.

Healthcare: EUR272.67bn (US$379.01bn) in 2011 to EUR279.09bn (US$354.44bn) in 2012; +2.4% in local currency terms and -6.5% in US dollar terms. Forecast unchanged from Q4 12.

Medical devices: EUR14.97bn (US$20.81bn) in 2011 to EUR15.62bn (US$19.83bn) in 2012; +4.3% in local currency terms and -4.7% in US dollar terms. Forecast unchanged from Q4 12.

Risk/Reward Rating: In our Pharmaceutical Risk/Reward Ratings (RRRs) for Q113, Germany remains ranked third in Western Europe, behind Switzerland and the UK. Despite the tough pricing and reimbursement conditions and the effects of patent expirations, Germany remains one of the largest global pharmaceutical markets, which will continue to prop up its rewards score. Its risks are also expected to remain above the regional average, which is illustrative of the favourable operating environment.

Competitive Landscape

The Competitive Landscape section provides comparative company analyses and rankings by US$ sales and % share of total sales - for the total pharmaceutical sector, as well as the OTC, generics, and distribution sub-sectors.
EXECUTIVE SUMMARY

SWOT ANALYSIS

    Germany Pharmaceuticals And Healthcare Industry SWOT
    Germany Political SWOT
    Germany Economic SWOT
    Germany Business Environment SWOT

PHARMACEUTICAL RISK/REWARD RATINGS

    Table: Western Europe Pharmaceutical Risk/Reward Ratings, Q113
    Rewards
    Risks

GERMANY – MARKET SUMMARY

REGULATORY REGIME

    Table: BfArM Drug Registration Activity, 2006-10
    Intellectual Property Regime
    Pricing Regime
    Table: Price Build-Up In The German Pharmaceutical Market
    Pricing Developments
    Table: AMNOG Drug Assessments
    Reimbursement Regime
    Table: Top 10 GKV Selling Drug Brands, 2009-2010 (EURmn)
    Reimbursement Developments
    Parallel Imports

INDUSTRY DEVELOPMENTS

    Epidemiology
    Healthcare Sector
    Health Insurance
    Healthcare Sector Reforms
    Research & Development
    Biotechnology Sector
    Table: Biotechnology Sector, 2008-09
    Clinical Trials
    Medical Devices Industry
    Developments In The Medical Devices Industry

INDUSTRY FORECAST SCENARIO

    Overall Market Forecast
    Table: Pharmaceutical Sales Indicators 2008-2016
    Healthcare Market Forecast
    Table: Healthcare Expenditure Indicators 2008-2016
    Table: Healthcare Governmental Indicators 2008-2016
    Table: Healthcare Private Indicators 2008-2016
    Key Growth Factors – Macroeconomic
    Table: Germany –GDP By ]Expenditure, Real Growth %
      Prescription Drug Market Forecast
      Table: Retail Pharmaceutical Expenditure, 2003-10 (Euro Billions)
      Table: Retail Pharmaceutical Expenditure, 2003-10 (Packages, Millions)
      Table: Retail Pharmaceutical Expenditure, 2003-10 (Average Price per Pack, Euros)
      Table: Prescription Drug Sales Indicators 2008-2016
      Patented Drug Market Forecast
      Table: Patented Drug Market Indicators 2008-2016
  Generic Drug Market Forecast
      Table: Generic Drug Sales Indicators 2008-2016
      OTC Medicine Market Forecast
      Table: OTC Medicine Sales Indicators 2008-2016
      Table: OTC Market by Leading Categories, 2004-2010 (EURmn)
      Pharmaceutical Trade Forecast
      Table: Exports and Imports Indicators 2009-2016
      Medical Device Market Forecast
      Table: Medical Devices Sales Indicators 2009-2016
      Other Healthcare Data
      Key Risks To BMI’s Forecast Scenario

COMPETITIVE LANDSCAPE

      Pharmaceutical Industry
      Table: Pharmaceutical Production, 1990-10
      Table: Leading German Pharmaceutical Companies
      Company Developments
      Wholesale Sector
      Table: Members of the Association of Pharmaceutical Wholesalers (PHAGRO), 2012
      Wholesale Sector Developments
      Retail Sector
      Retail Sector Developments

COMPANY PROFILES

  Local Companies
      Bayer HealthCare
      Boehringer Ingelheim
      Stada Arzneimittel
      Grünenthal
      Merck KGaA
  Multinational Companies
      GlaxoSmithKline (GSK)
      Pfizer
      Novartis
      Sanofi
      Merck & Co
      Table: Population By Age Group, 1990-2020 (‘000)
      Table: Population By Age Group, 1990-2020 (% of total)
      Table: Key Population Ratios, 1990-2020
      Table: Rural And Urban Population, 1990-2020

GLOSSARY

BMI METHODOLOGY

      How We Generate Our Pharmaceutical Industry Forecasts

RISK/REWARD RATINGS METHODOLOGY

RATINGS OVERVIEW

TABLE: PHARMACEUTICAL BUSINESS ENVIRONMENT INDICATORS

WEIGHTING

TABLE: WEIGHTING OF COMPONENTS

SOURCES
Skip to top


The Pharmaceutical Market: Colombia US$ 1,295.00 Jan, 2013 · 114 pages
The Pharmaceutical Market: Croatia US$ 1,295.00 Jan, 2013 · 86 pages
The Pharmaceutical Market: Cuba US$ 1,295.00 Mar, 2013
The Pharmaceutical Market: Czech Republic US$ 1,295.00 Jan, 2013 · 90 pages

Ask Your Question

The Pharmaceutical Market: Germany
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: